EHA 2017 | An update on kinase inhibitors from EHA 2017
Barbara Eichhorst
• 23 Jun 2017
Barbara Eichhorst, MD from University Clinic of Cologne,
Germany, gives us an update on kinase inhibitors both in development and in the clinic. She discusses ibrutinib long-term follow-up data, idelalisib combined with rituximab and venetoxlax.
